Earnings Call · Q1 FY2025·2025-05-07

Q1 25EPS +13.04%·Rev n/aQ4 24EPS +1.43%·Rev n/aQ3 24EPS +4.55%·Rev n/aQ2 24EPS +10.91%·Rev n/a⚠ consensus missing

TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA

Christopher Stevo — Head of Investor Relations

Richard Francis — Chief Executive Officer

Eli Kalif — Chief Financial Officer

Eric A. Hughes — Head of Research and Development

+9.2%1d on move date+8.8% vs SPY3d+5.0%5d+8.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TEVA calls or request research access.

More TEVA calls Browse calls Request research access